Home > News > Diversa Granted U.S. Patent
August 11th, 2003
Diversa Granted U.S. Patent
Diversa Corporation (Nasdaq: DVSA) today announced that it has been issued U.S. Patent No. 6,602,675, expanding its proprietary position for identifying biologically active molecules from the environment. The patent is directed to small molecule and enzyme discovery from both cultured and uncultured filamentous fungi and bacteria using high-throughput fluorescent screening. In addition to their utility for discovering novel enzyme products for agricultural and chemical applications, the technologies covered in this patent are an important part of Diversaís small molecule discovery platform, which includes high-throughput culturing and recombinant expression for developing natural product drug candidates.
2013 Nanotechnology Patent Literature Review: Graphitic Carbon-Based Nanotechnology and Energy Applications Are on the Rise February 13th, 2014
UCF Researcher Bringing 3-D TV Back From The Dead February 12th, 2014
Additive Manufacturing Expert Leila Ladani Joins UConn Faculty February 11th, 2014
FEI Buys Digital Rock Solutions Provider and microCT Product: Lithiconís Solutions Will Expand FEIís Oil & Gas Industry Offerings February 5th, 2014